Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-055741
Filing Date
2010-11-04
Accepted
2010-11-04 06:15:43
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17606_110q.htm 10-Q 868666
2 EX-31.1 a10-17606_1ex31d1.htm EX-31.1 11173
3 EX-31.2 a10-17606_1ex31d2.htm EX-31.2 11623
4 EX-32.1 a10-17606_1ex32d1.htm EX-32.1 8797
5 GRAPHIC g176061ba05i001.jpg GRAPHIC 366
  Complete submission text file 0001104659-10-055741.txt   902146
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 101163091
SIC: 2834 Pharmaceutical Preparations